{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/163710"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/163710","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Machine Learning Methods for Single Cell RNA-Sequencing Data to Improve Clinical Oncology","abstract":"Single-cell RNA sequencing (scRNA-seq) offers a detailed view of the cellular and phenotypic composition of healthy and diseased tissues. While machine learning (ML) methods are well-suited for the high-dimensional nature of scRNA-seq data, current computational tools face limitations, particularly when confronted with data from clinical oncology. This thesis presents the development and application of ML techniques for scRNA-seq data to address key computational challenges, with a focus on challenges in clinical oncology. It covers four key areas: identifying gene signatures and biomarkers in multiple myeloma, developing methods to account for somatic copy number variations in tumor samples, benchmarking large, pre-trained scRNA-seq foundation models, and creating a framework for predicting clinical outcomes using patient-level representations of single-cell data. Together, these studies aim to develop and evaluate novel ML algorithms for scRNA-seq data which can unlock actionable insights for personalized medicine.","abstract_html":"Single-cell RNA sequencing (scRNA-seq) offers a detailed view of the cellular and phenotypic composition of healthy and diseased tissues. While machine learning (ML) methods are well-suited for the high-dimensional nature of scRNA-seq data, current computational tools face limitations, particularly when confronted with data from clinical oncology. This thesis presents the development and application of ML techniques for scRNA-seq data to address key computational challenges, with a focus on challenges in clinical oncology. It covers four key areas: identifying gene signatures and biomarkers in multiple myeloma, developing methods to account for somatic copy number variations in tumor samples, benchmarking large, pre-trained scRNA-seq foundation models, and creating a framework for predicting clinical outcomes using patient-level representations of single-cell data. Together, these studies aim to develop and evaluate novel ML algorithms for scRNA-seq data which can unlock actionable insights for personalized medicine.","abstract_has_math":false,"creators":["Boiarsky, Rebecca"],"institution":"Massachusetts Institute of Technology","degree_name":"Doctoral","degree_level":null,"degree_discipline":null,"degree_department":"Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science","school":null,"contributors":[],"advisors":["Sontag, David","Getz, Gad"],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025-05","date_published":"2025-05","updated_at":"2026-07-22T22:20:59Z","subjects":[],"languages":[],"rights":["Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)","Copyright retained by author(s)"],"rights_urls":["https://creativecommons.org/licenses/by-nc-nd/4.0/"],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1721.1/163710","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Sontag, David","Getz, Gad"]},{"key":"dc:contributor.department","label":"Department","values":["Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science"]},{"key":"dc:creator","label":"Author","values":["Boiarsky, Rebecca"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2025-11-17T19:08:41Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2025-11-17T19:08:41Z"]},{"key":"dc:date.issued","label":"Date","values":["2025-05"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctoral","Doctor of Philosophy"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)","Copyright retained by author(s)"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://creativecommons.org/licenses/by-nc-nd/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1721.1/163710"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Single-cell RNA sequencing (scRNA-seq) offers a detailed view of the cellular and phenotypic composition of healthy and diseased tissues. While machine learning (ML) methods are well-suited for the high-dimensional nature of scRNA-seq data, current computational tools face limitations, particularly when confronted with data from clinical oncology. This thesis presents the development and application of ML techniques for scRNA-seq data to address key computational challenges, with a focus on challenges in clinical oncology. It covers four key areas: identifying gene signatures and biomarkers in multiple myeloma, developing methods to account for somatic copy number variations in tumor samples, benchmarking large, pre-trained scRNA-seq foundation models, and creating a framework for predicting clinical outcomes using patient-level representations of single-cell data. Together, these studies aim to develop and evaluate novel ML algorithms for scRNA-seq data which can unlock actionable insights for personalized medicine."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Ph.D."]},{"key":"dc:title","label":"Title","values":["Machine Learning Methods for Single Cell RNA-Sequencing Data to Improve Clinical Oncology"]}]}],"canonical_facts":{"dc:contributor.advisor":["Sontag, David","Getz, Gad"],"dc:contributor.department":["Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science"],"dc:creator":["Boiarsky, Rebecca"],"dc:date.accessioned":["2025-11-17T19:08:41Z"],"dc:date.available":["2025-11-17T19:08:41Z"],"dc:date.issued":["2025-05"],"dc:description.abstract":["Single-cell RNA sequencing (scRNA-seq) offers a detailed view of the cellular and phenotypic composition of healthy and diseased tissues. While machine learning (ML) methods are well-suited for the high-dimensional nature of scRNA-seq data, current computational tools face limitations, particularly when confronted with data from clinical oncology. This thesis presents the development and application of ML techniques for scRNA-seq data to address key computational challenges, with a focus on challenges in clinical oncology. It covers four key areas: identifying gene signatures and biomarkers in multiple myeloma, developing methods to account for somatic copy number variations in tumor samples, benchmarking large, pre-trained scRNA-seq foundation models, and creating a framework for predicting clinical outcomes using patient-level representations of single-cell data. Together, these studies aim to develop and evaluate novel ML algorithms for scRNA-seq data which can unlock actionable insights for personalized medicine."],"dc:description.degree":["Ph.D."],"dc:identifier.uri":["https://hdl.handle.net/1721.1/163710"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)","Copyright retained by author(s)"],"dc:rights.uri":["https://creativecommons.org/licenses/by-nc-nd/4.0/"],"dc:title":["Machine Learning Methods for Single Cell RNA-Sequencing Data to Improve Clinical Oncology"],"dc:type":["Thesis"],"thesis:degree_name":["Doctoral","Doctor of Philosophy"]},"updated_at":"2026-07-22T22:20:59Z"}